Heartflow (HTFL) Stock Price & Analysis

HTFL$48.46-11.46 -19.13%
Medical - Healthcare Information Services
Compare
Market cap$4.21BEnterprise value$4.21BRevenue (TTM)$238.66MMarket position—

Score

41
Bearish
Value
24
Quality
45
Growth
55

AI Analysis

Snapshot

Heartflow, Inc. Common Stock doesn’t screen as a clean setup today — Stocklytics 41/100 leaves more to prove. Under the hood: revenue compounding ~42% annually over recent years.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

24
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

55
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

45
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Heartflow, Inc. Common Stock (HTFL) last printed $48.46. Equity value is $4.21B. Trailing earnings multiple —. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

202320242025
$87.17M$125.81M$176.03M

About

HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.

Heartflow (HTFL) Stock Price & Analysis

HTFL price $48.46 -11.46 -19.13%

Ticker
HTFL
Price
$48.46
Change
-11.46 -19.13%
Market cap
$4.21B
Dividend yield
0.00%
Beta
2.02
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Stocklytics score
41
Value
24
Quality
45
Growth
55

Stocklytics score rationale: value 24, quality 45, growth 55.

Fair value

HTFL fair value Not meaningful. Price $48.46.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price.

Fair value blends a 10-year DCF and an earnings multiple: the average of the DCF value and an earnings value from next-twelve-months EPS times 30.0, a blend of the industry median and the stock's own 10-year median. How we calculate it →

Not meaningful. The model is more than 80% below the live price, which happens for unprofitable or very early companies and is not a price target.

Compare HTFL

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2027-03-17—-0.09—72.40M
2026-11-12-0.03-0.1072.86M65.19M
2026-08-13-0.07-0.1364.08M56.64M
2026-05-14-0.16-0.1952.59M49.71M
2026-03-18-0.12-0.1949.13M46.58M
2025-11-12-0.27-0.2046.28M46.30M
2025-09-19-0.06-0.2143.41M43.20M
2025-07-17-0.46-0.2137.20M43.20M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-11-10Farquhar John C.M.Sell15.62K$2.2234.68K
2026-11-10Farquhar John C.M.Buy15.62K$2.2234.68K
2026-11-10Farquhar John C.M.Sell38.90K$55.742.17M
2026-11-09Verghese VikramSell3.59K$53.15190.65K
2026-11-06Farquhar John C.M.Sell7.75K$52.40406.15K
2026-11-06Verghese VikramSell2.01K$52.40105.27K
2026-11-06Rogers CampbellSell2.27K$52.40118.95K
2026-11-06Jones Marie L.Sell568$52.4029.76K
2026-10-22Rogers CampbellBuy5.10K$2.2211.32K
2026-10-22Rogers CampbellBuy12.33K$8.33102.70K
2026-10-22Rogers CampbellSell23.93K$55.011.32M
2026-10-22Rogers CampbellSell5.10K$2.2211.32K
2026-10-22Rogers CampbellSell12.33K$8.33102.70K
2026-10-12Farquhar John C.M.Sell38.90K$49.571.93M
2026-09-18Rogers CampbellBuy850$2.221.89K
2026-09-18Rogers CampbellBuy12.33K$8.33102.70K
2026-09-18Rogers CampbellSell19.68K$50.15987.05K
2026-09-18Rogers CampbellSell850$2.221.89K
2026-09-18Rogers CampbellSell12.33K$8.33102.70K
2026-09-18Verghese VikramSell16.77K$50.75850.93K
2026-09-17Verghese VikramSell7.58K$50.11379.82K
2026-09-15Verghese VikramSell668$50.0133.41K
2026-09-14Verghese VikramSell4.59K$50.24230.74K
2026-09-11Verghese VikramSell29.71K$50.061.49M
2026-09-11Farquhar John C.M.Sell3.89K$50.00194.50K
2026-09-10Farquhar John C.M.Sell35.01K$46.421.63M
2026-09-08Jones Marie L.Buy795$19.7015.66K
2026-09-08Verghese VikramSell6.64K$50.03332.21K
2026-09-03Verghese VikramSell27.54K$49.691.37M
2026-09-02Verghese VikramSell5.88K$50.60297.33K
2026-08-21Farquhar John C.M.Sell27.23K$50.001.36M
2026-08-18Farquhar John C.M.Sell32.68K$45.001.47M
2026-08-17Rogers CampbellBuy9.22K$19.00175.16K
2026-08-17Rogers CampbellSell9.22K$41.23380.10K
2026-08-17Rogers CampbellSell9.22K$19.00175.16K
2026-08-14Farquhar John C.M.Sell15.56K$39.06607.77K
2026-08-10Farquhar John C.M.Sell22.56K$28.31638.73K
2026-08-07Jones Marie L.Sell82$28.822.36K
2026-08-07Verghese VikramSell473$28.8213.63K
2026-08-07Rogers CampbellSell637$28.8218.36K
2026-08-07Farquhar John C.M.Sell1.90K$28.8254.87K
2026-08-06Jones Marie L.Sell486$27.1913.21K
2026-08-06Verghese VikramSell1.54K$27.1941.79K
2026-08-06Rogers CampbellSell1.64K$27.1944.46K
2026-08-06Farquhar John C.M.Sell5.85K$27.19158.98K
2026-07-30Farquhar John C.M.Sell18.69K$2.2241.50K
2026-07-30Farquhar John C.M.Buy9.74K$9.5893.28K
2026-07-30Farquhar John C.M.Buy18.69K$2.2241.50K
2026-07-30Farquhar John C.M.Buy2.79K$8.3323.23K
2026-07-30Farquhar John C.M.Sell9.74K$9.5893.28K
2026-07-30Farquhar John C.M.Sell2.79K$8.3323.23K
2026-07-27Verghese VikramBuy22.52K$2.2250.00K
2026-07-27Verghese VikramSell22.52K$2.2250.00K
2026-07-24Lightcap Jeffrey CBuy47.42K$19.00900.98K
2026-07-24Lightcap Jeffrey CSell47.42K$19.00900.98K
2026-07-22BARABE TIMOTHY CBuy3.71K$19.0070.49K
2026-07-22BARABE TIMOTHY CSell3.71K$19.0070.49K
2026-07-21Verghese VikramBuy22.52K$2.2250.00K
2026-07-21Verghese VikramSell22.52K$2.2250.00K
2026-07-17BARABE TIMOTHY CBuy5.00K$19.0095.00K
2026-07-17BARABE TIMOTHY CSell5.00K$19.0095.00K
2026-07-15Rogers CampbellBuy9.22K$19.00175.16K
2026-07-15Rogers CampbellSell9.22K$19.00175.16K
2026-07-15Rogers CampbellSell9.22K$25.72237.11K
2026-07-10Farquhar John C.M.Sell22.56K$27.75626.10K
2026-07-08WELDON WILLIAM CBuy17.12K$8.33142.63K
2026-07-08WELDON WILLIAM CBuy17.12K$8.33142.63K
2026-07-08WELDON WILLIAM CBuy17.12K$8.33142.63K
2026-07-08WELDON WILLIAM CSell17.12K$8.33142.63K
2026-06-24Farquhar John C.M.Sell38.90K$35.001.36M
2026-06-16WELDON WILLIAM CBuy16.07K$32.05515.20K
2026-06-16BARABE TIMOTHY CBuy16.07K$32.05515.20K
2026-06-16Cullivan Julie ABuy16.07K$32.05515.20K
2026-06-16Lightcap Jeffrey CBuy16.07K$32.05515.20K
2026-06-16Riley Wayne JosephBuy16.07K$32.05515.20K
2026-06-16Tansey Casey MBuy16.07K$32.05515.20K
2026-06-15Rogers CampbellBuy10.00K$2.2222.20K
2026-06-15Rogers CampbellSell10.00K$2.2222.20K
2026-06-10Farquhar John C.M.Sell22.56K$28.50643.02K
2026-05-18Rogers CampbellSell9.22K$19.00175.16K
2026-05-18Rogers CampbellBuy9.22K$19.00175.16K
2026-05-18Rogers CampbellSell9.22K$28.34261.27K
2026-05-11Farquhar John C.M.Sell22.56K$29.12657.01K
2026-05-07Jones Marie L.Sell82$29.982.46K
2026-05-07Rogers CampbellSell637$29.9819.10K
2026-05-07Verghese VikramSell473$29.9814.18K
2026-05-07Farquhar John C.M.Sell1.90K$29.9857.08K
2026-05-06Jones Marie L.Sell485$30.2914.69K
2026-05-06Rogers CampbellSell1.63K$30.2949.49K
2026-05-06Verghese VikramSell1.54K$30.2946.53K
2026-05-06Farquhar John C.M.Sell5.30K$30.29160.54K
2026-04-30Bain Capital Life Sciences Investors, LLCSell892.53K$29.1826.04M
2026-04-30Bain Capital Life Sciences Investors, LLCSell56.22K$30.051.69M
2026-04-29Bain Capital Life Sciences Investors, LLCSell797.13K$29.3723.41M
2026-04-28Bain Capital Life Sciences Investors, LLCSell254.11K$30.517.75M
2026-04-10Farquhar John C.M.Sell22.56K$26.72602.86K
2026-04-01Rogers CampbellBuy6.85K$2.2215.20K
2026-04-01Rogers CampbellBuy40.77K$2.2290.50K
2026-03-06Jones Marie L.Buy1.66K$16.1526.83K
2026-03-06Verghese VikramBuy671$16.1510.84K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 200, holders +29 vs prior quarter. Ownership 20.39%.

HolderSharesChangeChange %Value
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC8.45M-2.00M-19.14%247.87M
WELLINGTON MANAGEMENT GROUP LLP7.86M-4.12M-34.37%230.74M
BLACKROCK, INC.5.20M3.74M+255.38%152.50M
FMR LLC4.82M-576.86K-10.69%141.45M
VANGUARD PORTFOLIO MANAGEMENT LLC3.58M1.54M+75.20%105.17M
BAMCO INC /NY/3.23M-602.40K-15.74%94.63M
VANGUARD CAPITAL MANAGEMENT LLC2.75M859.71K+45.40%80.78M
JUPITER TOPCO LLC2.42M2.42MNew70.98M
INVESCO LTD.2.30M385.63K+20.16%67.44M
POINT72 ASSET MANAGEMENT, L.P.1.72M1.18M+219.73%50.50M
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC1.69M802.56K+89.96%49.72M
ALLIANCEBERNSTEIN L.P.1.92M699.94K+57.17%46.82M
STATE STREET CORP1.47M1.02M+225.36%43.27M
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC1.47M50.82K+3.59%43.00M
GEODE CAPITAL MANAGEMENT, LLC1.36M818.73K+151.15%39.92M
NUVEEN, LLC1.35M1.35MNew39.70M
MORGAN STANLEY1.05M202.96K+23.82%30.95M
UBS GROUP AG975.51K546.43K+127.35%28.62M
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A.931.16K931.16KNew27.32M
MILLENNIUM MANAGEMENT LLC922.89K-170.52K-15.60%27.08M
12 WEST CAPITAL MANAGEMENT LP902.50K262.50K+41.02%26.48M
FRANKLIN TEMPLETON INC817.70K23.98K+3.02%23.99M
CITADEL ADVISORS LLC799.88K43.28K+5.72%23.47M
CHAMPLAIN INVESTMENT PARTNERS, LLC733.61K166.18K+29.29%21.52M
VOYA INVESTMENT MANAGEMENT LLC733.18K5.52K+0.76%21.51M

Insights · Forecast · Financials · Learn

Stocklytics home · Screener